|
|
||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
1Department of Molecular Biology and 2Institute of Clinical Medicine, University of Aarhus, Aarhus; 3August Krogh Institute, University of Copenhagen, Copenhagen; 4Department of Medical Physiology, The Panum Institute, University of Copenhagen, Copenhagen; 5NeuroSearch A/S, Ballerup; 6Department of Chemistry, University of Aarhus, Aarhus; and 7Department of Basic Animal and Veterinary Sciences, The Royal Veterinary and Agricultural University, Frederiksberg, Denmark
Submitted 14 January 2006 ; accepted in final form 24 May 2006
| ABSTRACT |
|---|
|
|
|---|
inorganic phosphate transport; retroviral receptor; SLC20
The mammalian type III transporters are part of the Pi transport (PiT) family [SLC20 (43); TC #2.A.20 (29)], but several members were originally identified as receptors for retroviruses belonging to the gammaretrovirus genus (18, 19, 21, 37, 42, 45); thus PiT1 and PiT2 are proteins that exhibit dual functions.
The PiT paralogs are highly related, and human PiT1 and PiT2 share overall 62% amino acid sequence identity with a higher degree of homology at the NH2- and COOH-terminal ends (21, 42). Hydropathy profiles show that the PiT paralogs are polytopic proteins and predict 1012 transmembrane domains (4, 9, 14, 32) and a large hydrophilic domain near the center of each protein that has been experimentally assigned to the cytoplasmic space in PiT2 (6).
PiT1 and PiT2 show a broad tissue distribution, both being expressed in all investigated human tissues, albeit at different levels (40), and low extracellular Pi levels can result in upregulated PiT1 and PiT2 expression in mammalian cells (7, 17), which, together with the current knowledge, albeit limited, on their transport characteristics, suggests that they constitute the housekeeping Pi uptake system between cells and the extracellular fluid (7, 16, 17, 40). This entails that PiT1 and PiT2 have to possess the abilities to adjust to a wide range of extracellular surroundings and organ-specific milieus in the body. Moreover, the PiT proteins also were recently found to be implicated in chondro- and osteoblastic mineralization (3, 20, 24) as well as the phenomenon of transdifferentiation of vascular smooth muscle cells to osteoblast-like cells in the process of vascular calcification under hyperphosphatemic conditions (reviewed in Ref. 11).
Despite the essential role of Pi in life processes and the specific roles of PiT1 and PiT2 in supplying mammalian cells with their general Pi need, as well as the increasing evidence for the role of type III transporters in normal and pathological calcification, little is known about the basic transport functions of the individual proteins. Using the Xenopus laevis oocyte as a "host" in the present study allowed us to investigate the basal capacities of either of the human PiT proteins in surroundings without the influence of uncontrollable variables coupled to cell line-specific characteristics dependent on, for example, organ of origin. No previous study has addressed the basic NaPi transport characteristics of human PiT2, but some of these characteristics already have been analyzed for human PiT1 (16, 17) and rodent PiT proteins (rat PiT1 and mouse and rat PiT2) (1, 17, 40).
The functional characterization of human PiT1 and PiT2 presented in this study shows that although they differ in their transport kinetics with PiT2, showing positive cooperativity in Pi uptake, they also behave remarkably alike. For example, they both support Na+-dependent Pi uptake at acidic and alkaline pH values, and their Na+ requirements for Pi transport also are similar. However, only human PiT2 supports Na+-independent Pi uptake, albeit at low levels, at acidic pH, underscoring another difference in the transport capacities among these two quite similar proteins. Moreover, Ca2+ or Ca2+ and Mg2+ were found to increase PiT1- and PiT2-mediated NaPi import, but neither cation was critical for the transport functions in that, compared with transport in the presence of both divalent cations, omitting Ca2+ and Mg2+ only resulted in an
50% reduction in Pi uptake for both proteins. Interestingly, in the absence of Ca2+, Mg2+ could partially substitute Ca2+ for PiT1 but not for PiT2, implying another difference in their Pi transport mechanisms. We also addressed the Na+ transport function versus the Pi import function of PiT2 and included a mutant PiT2 protein lacking the ability to sustain Pi uptake (5). These studies showed that wild-type PiT2 transported Na+ regardless of whether Pi was available for import or not. Moreover, the mutant PiT2 protein with knocked out Pi uptake function supported wild-type levels of Na+ transport, allowing us to suggest two putative transmembrane glutamate residues as being responsible for the coupling of Pi import to Na+ transport in wild-type PiT2.
| MATERIALS AND METHODS |
|---|
|
|
|---|
X. laevis oocytes. Female X. laevis frogs were obtained from Nasco (Modesto, CA) and were kept and handled according to guidelines approved by the Danish National Committee for Animal Studies. Oocytes were isolated from frogs anesthetized in a 0.10.2% MS.222 (3-aminobenzoic acid ethyl ester; Sigma, St. Louis, MO) solution for 1030 min. A 1- to 1.5-cm incision was made in the abdomen, and several ovaries were removed surgically by authorized personnel.
The oocytes were manually dissected and subsequently treated with collagenase (Sigma) and maintained in modified Barth's solution [88 mM NaCl, 1 mM KCl, 0.82 mM MgSO4, 0.4 mM CaCl2, 0.33 mM Ca(NO3)2, 2.4 mM NaHCO3, 10 mM HEPES-KOH, pH 7.5, 100 IU/ml penicillin, and 100 µg/ml streptomycin] at 18°C as described previously (5). The following day, the oocytes were ready for cRNA or H2O injection.
32Pi transport assays in X. laevis oocytes. The 32Pi transport assays in X. laevis oocytes were essentially done as described previously (5). Briefly, restriction enzyme Bln1 or Not1 was used to linearize the pOJ74 plasmid, Bln1 or Apa1 was used to linearize the pOJ75 plasmid, and Sfi1 was used to linearize the pOJ9 plasmid. Notice that Apa1, Bln1, and Sfi1 cut in the vector sequence downstream of the polylinker and Not1 cuts in the polylinker immediately after the 3'-untranslated region (UTR) of PiT2. Moreover, except for a few bases, Bln1 and Sfi1 cut pOJ75 and pOJ9, respectively, in corresponding positions. Thereafter, we applied the mMESSAGE mMACHINE kit (Ambion, Austin, TX) to produce cRNAs according to the manufacturer's instructions. The quality of the cRNA preparations was verified by agarose gel electrophoresis before injection as well as on remaining samples of the diluted cRNA preparations used for injection.
Stage V and VI oocytes were microinjected with 12.5 ng of cRNA (or H2O as negative control) 1 day after surgery and incubated at 18°C. After 2 or 3 days, we applied a standardized Na32Pi transport protocol in which the oocytes were washed in Pi-free uptake solution (100 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES-KOH, pH 7.5), and uptake was allowed for 1 h at 18°C in 0.1 mM KH232PO4 (2 mCi/ml; New England Nuclear, Boston, MA) diluted in Pi-free uptake solution. The oocytes were subsequently washed in ice-cold Pi-free uptake solution containing 5 mM KH2PO4, and 32Pi uptake of each oocyte was measured in a liquid scintillation counter as described previously (5). This protocol was modified in individual experiments as indicated.
For determination of the affinity constants Km and K0.5 for Pi, oocytes were incubated for 5 min in uptake solution containing KH232PO4 in concentrations varying from 1,000 to 7.8 µM. For determination of the pH-dependent Na32Pi uptake pattern, oocytes were incubated for 1 h in uptake solutions modified to reach pH values ranging from 4.5 to 5.5 and 6.5 with HCl and to 8.5 with KOH. More acidic conditions could not be analyzed because the oocytes did not tolerate pH 3.5.
Na+-independent 32Pi transport was analyzed at pH values ranging from 5.5 to 7.5 with Tris·HCl substituting for NaCl; pH was adjusted to 6.5 and 7.5 with KOH and to 5.5 with HCl, otherwise the uptake solutions were comparable to the ones used for pH-dependent Na32Pi uptake studies. The dependency of Na32Pi transport on Mg2+ and/or Ca2+ was analyzed by incubating oocytes in 0.1 mM KH232PO4 in Pi-free uptake solution without Mg2+ or Ca2+ or without both Mg2+ and Ca2+.
For analysis of Na+ dependency of 32Pi transport function, 32Pi uptake was analyzed using Na+ concentrations ranging from 0.5 to 100 mM. The uptake solution was supplemented with Tris·HCl at pH 7.5 to reach a final concentration of 100 mM Tris/Na+.
22Na+ transport assay in X. laevis oocytes. Plasmids encoding PiT2 (pOJ74) and PiT2 E55Q E91Q E575Q were linearized with Not1, and cRNAs were made as described above. H2O or 25 ng of cRNA was injected into each oocyte, and after 3 days, 22Na+ uptake studies were performed in Pi-free uptake solution (100 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES-KOH, pH 7.5) containing 5.8 µM 22NaCl (11.6 mCi/ml: Amersham Biosciences, Uppsala, Sweden). Moreover, 22Na+ uptake in the presence of Pi was analyzed in the same way by supplementing the uptake solution with 5 mM KH2PO4. Uptake was allowed for 1 h, and the oocytes were washed in ice-cold uptake solution. Fifteen oocytes were used per setup, and 22Na+ uptake was measured as gamma decay on pools of five oocytes in a Packard Cobra II Auto gamma counter (Packard Instruments, Canberra, Australia).
Kinetics and statistical analyses.
Substrate kinetics calculations for PiT1 were determined by nonlinear regression to the Michaelis-Menten equation:
, where
represents the initial rate of uptake at a given substrate concentration, Vmax is the maximal rate of uptake at saturating substrate concentrations, [S] is the concentration of substrate, and KmPi is the Michaelis-Menten constant representing the substrate concentration that produces one-half Vmax. Substrate kinetics calculations for PiT2 were determined by nonlinear regression to a sigmoidal dose-response (variable slope) equation:
, where the slope h denoting the Hill coefficient reveals positive cooperativity if >1, and K0.5 represents the substrate concentration that produces one-half Vmax. Both analyses were performed using GraphPad Prism version 4.01 for Windows (GraphPad Software, San Diego, CA; www.graphpad.com).
For ordinary transport function comparison of two sets of data, the hypothesis that two mean values were identical was tested using a two-tailed Student's t-test. Values were considered different at a 95% confidence level.
Calculation of chemical speciation. Calculation of the chemical speciation in the uptake solutions was performed using MINEQL+ version 3.01b Chemical Equilibrium Management System, distributed by Environmental Research Software (33, 34). For most uptake solutions used at a pH >5.5, the program predicts the presence of precipitates. However, no precipitates were evident in any of the uptake solutions used except at pH 8.5, where slight precipitation was formed after 3 days. Therefore, in all calculations precipitates were neglected. HEPES was not included in the calculations because it does not form complexes with the cations present in the uptake solutions (12); however, its contribution to the ionic strength was taken into consideration.
| RESULTS |
|---|
|
|
|---|
|
Expression of PiT1 protein in X. laevis oocytes is influenced by enzyme choice in the cRNA preparation process. An important aspect of working with protein expression in oocytes is the step of making cRNAs from plasmid preparations. At first, we used the enzymes Apa1 and Not1 for linearization of PiT1- and PiT2-encoding plasmids, respectively. Apa1 linearizes 549 base pairs (bp) downstream of the 126-bp-long PiT1-specific 3'-UTR fragment in pOJ75, whereas Not1 linearizes 13 bp downstream of the 541-bp-long PiT2-specific 3'-UTR fragment in pOJ74. However, to make relative comparisons of PiT2 and PiT1 more feasible, we switched to an enzyme (Bln1) applicable for both pOJ74 and pOJ75; Bln1 linearizes 845 bp and 306 bp downstream of the Not1 site in pOJ74 and the Apa1 site in pOJ75, respectively.
Comparison of PiT2 cRNAs transcribed from Bln1- and Not1-linearized pOJ74 with our standardized Na32Pi transport protocol resulted in PiT2-expressing oocytes supporting equal (P = 0.171) levels of Na32Pi uptake (see Table 1, experiment 1), thus both Not1 and Bln1 are suitable enzymes when preparing PiT2 cRNAs from pOJ74. Moreover, we compared PiT1 cRNA transcribed from Apa1-linearized pOJ75 with PiT2 cRNA from Not1-linearized pOJ74 (see Table 1, experiment 2) as well as PiT1 cRNA transcribed from Bln1-linearized pOJ75 with PiT2 cRNA made from Bln1-linearized pOJ74 (see Table 1, experiments 1 and 3). PiT1 cRNA from Apa1-linearized pOJ75 gave rise to oocytes transporting significantly lower levels of 32Pi than oocytes injected with PiT2 cRNA from Not1-linearized pOJ74 (P < 0.001) (experiment 2). However, cRNAs made from Bln1-linearized pOJ74 and pOJ75 plasmids resulted in 32Pi uptake levels that were not statistically significantly different (P = 0.921 and P = 0.662, experiments 1 and 3, respectively). Thus, for PiT1 cRNA production from pOJ75, we suggest that Bln1 is used for linearization of the plasmid.
|
Human PiT2 displays linear NaPi uptake from 1 to 4 h when expressed in X. laevis oocytes. The time course of Pi uptake in the presence of Na+ showed that linear transport of 32Pi supported by PiT2-expressing and H2O-injected oocytes occurred in the range from 1 to 4 h (Fig. 2). We chose 1-h uptake for future experiments, because this time span resulted in data with lesser variation than longer transport periods did (see SE on Fig. 2). Allowing oocytes to transport for 1 h resulted in a PiT2 uptake of 114.4 ± 20.6 pmol 32Pi/oocyte (Fig. 2), in agreement with our former results obtained with PiT2-expressing oocytes (Table 1, experiments 1 and 2) (4, 5).
|
0.005). For both PiT1 and PiT2, there were tendencies to optimal 32Pi uptake at pH 6.5 and 7.5; however, for both proteins, comparison of 32Pi transport obtained at different pH values to that obtained at pH 7.5 revealed no data sets that were statistically significantly different (for P values, see Fig. 3 legend). Repetition of the experiments at pH values ranging from 5.5 to 8.5 gave similar results and statistics (not shown). Thus PiT1 and PiT2 sustain NaPi transport function at various pH values, in agreement with their ubiquitous expression in all human cells and tissues investigated (6, 28, 40).
|
|
|
54% (PiT1) and 58% (PiT2) compared with uptake in the presence of both divalent cations (P < 0.001 relative to H2O-injected oocytes in all cases) (Fig. 4). (For Pi species present in uptake solutions without Ca2+ and/or Mg2+, see Table 4 and 5). Thus, although neither protein was strictly dependent on Ca2+ and/or Mg2+ for Pi transport, the presence of at least one of the cations increased their Pi uptake. Mg2+ was dispensable for NaPi transport function when Ca2+ was present, whereas lack of Ca2+ resulted in impaired Pi uptake (Fig. 4). Thus the preferred divalent cation for NaPi transport function of the PiT proteins is Ca2+. However, in the absence of Ca2+, PiT1, but not PiT2, managed to use Mg2+ (P = 0.016 for PiT1 32Pi transport in the presence of Mg2+ compared with the absence of both divalent cations). The indifference of PiT2 transport function on the lack of Mg2+ was reexamined, and similar results were obtained (results not shown). These findings are interesting, because they indicate differences in the mechanism of Pi transport supported by PiT1 and PiT2. Moreover, the high levels of Pi uptake by PiT1 and PiT2 at pH 4.5 (Fig. 3), together with the observed abilities of both proteins to support Ca2+- and Mg2+-independent Pi uptake (Fig. 4), suggest that the effect of the divalent cations is to modulate the Pi transport capacities of the proteins, leading to increased uptake of H2PO4 and/or HPO42. Thus the mammalian PiT proteins have preserved the ability to employ divalent cations for transport of Pi, although they are not strictly dependent on them.
|
|
|
|
PiT1 lacks Na+-independent Pi transport function. We also investigated whether human PiT1 could sustain Na+-independent 32Pi transport function. Oocytes were injected with cRNAs from pOJ75 (Fig. 6A) or, in an independent experiment, with cRNAs transcribed from pOJ9 (Fig. 6B). Surprisingly, PiT1-expressing oocytes were not able to import 32Pi in a Na+-independent manner significantly better than H2O-injected oocytes at pH 5.5 (Fig. 6). However, oocytes injected with PiT1 cRNA made from pOJ75 plasmid did import 32Pi at a level significantly different from that of H2O-injected oocytes at pH 6.5 (P = 0.010) (Fig. 6A), but the difference in transport was less than twofold and was not observed in the experiment shown in Fig. 6B; thus PiT1 is unable to import Pi at acidic pH in a Na+-independent manner. Our study confirms another study analyzing human PiT1 in MDTF cells at pH 6.5 (22).
|
|
120 pmol 32Pi·oocyte1·h1, whereas at 10 mM Na+, the 32Pi uptake was
46 times lower, and reducing the Na+ concentration 10-fold to 1 mM only resulted in 32Pi uptake
22.5 times lower (Fig. 7). Hence, even at low levels of Na+, the PiT proteins are able to sustain a remarkable level of Pi uptake. Because the physiological Na+ concentration in the human body is in the range of 130145 mM, in vivo there always will be plenty to sustain Pi uptake via PiT1 and PiT2. Thus, whether the ability to sustain Pi import at low levels of Na+ is a relic from the past or does in fact constitute a physiologically relevant function of PiT1 and PiT2 remains to be investigated. Na+ and Pi symport functions can be uncoupled in PiT2. Na+ transport and Pi import are the two active events conducted by the PiT proteins, so to gain insight into the NaPi cotransport function, we analyzed PiT2 and a PiT2-derived Pi transport knockout mutant protein (PiT2 E55Q E91Q E575Q; mutant QQQ in Ref. 5) in oocytes by using 22Na+ as a traceable Na+ source. The mutant protein PiT2 E55Q E91Q E575Q lacks Pi transport function (Fig. 8B) (5), but the retroviral receptor function for two PiT2 cognate viruses is intact, implying that the mutant protein is correctly processed and that overall topology is preserved (5).
|
Moreover, comparison of the 22Na+ uptake levels obtained for wild-type PiT2 and PiT2 E55Q E91Q E575Q in the presence of Pi (P = 0.928) and in the absence of Pi (P = 0.732) revealed that both proteins supported comparable levels of 22Na+ uptake whether Pi were absent or present. Thus, in a Pi-rich environment, the Pi transport knockout PiT2 E55Q E91Q E575Q supported the same amount of 22Na+ transport as the wild-type PiT2 in an environment devoid of Pi (Fig. 8), showing that Na+ transport of human PiT2 can be uncoupled from Pi transport.
| DISCUSSION |
|---|
|
|
|---|
Whereas rat and mouse PiT2 have been analyzed previously in oocytes, this is the first report on human PiT2. Interestingly, our data reveal positive cooperativity (Hill coefficient of 2) in human PiT2 Pi transport function. This is in agreement with the observations that human PiT2 can be at dimeric form (5) and that Pi starvation promotes human PiT2 dimerization, suggesting that the transporting form is a dimer (30). We determined the K0.5Pi value of human PiT2 to be 163.5 ± 39.8 µM; however, rodent PiT2 were reported to obey Michaelis-Menten kinetics, and their KmPi values were determined to be 25.3 ± 6.0 µM (rat) (17) and 38 ± 12 µM (mouse) (1), respectively. The disparities regarding human and rodent PiT2 might be due to amino acid differences, because the overall homology between human and mouse PiT2 is 91% and that between mouse and rat PiT2 is 95% (1).
We determined the PiT1 Km value for Pi to be 322.5 ± 124.5 µM, and others have determined KmPi values for human (17) and rat PiT1 (38) in oocytes to be 24.1 ± 5.5 and 89 ± 13 µM, respectively. It cannot be excluded that the difference in KmPi values between human (present work) and rat PiT1 (38) reflects amino acid differences (human and rat PiT1 exhibit 90% overall sequence homology). Moreover, the KmPi value for human PiT1 determined in the present study and that determined by Kavanaugh et al. (17) differ by >13-fold. Kavanaugh et al. performed NaPi uptake in the presence of 1.8 mM CaCl2, whereas we applied 1.0 mM CaCl2, and because we found that human PiT1 can sustain Pi uptake without the presence of Ca2+ (or Mg2+) but that the presence of either at 1 mM increased human PiT1 Pi uptake (Fig. 4), we cannot exclude the possibility that the difference in Ca2+ levels contributes to the differences in KmPi values obtained for human PiT1.
The PiT1 KmPi and PiT2 K0.5Pi values we obtained in oocytes are in good agreement with former studies on endogenously expressed human PiT proteins, which revealed KmPi values of 454 ± 61 µM in human osteoblastic SaOS2 cells (23), 280 ± 30 µM in human primary erythrocytes (35), 360 µM in human erythroid precursor-like K562 cells (39), 110 ± 20 µM in human cervical epithelial-like HeLa cells (27), and 147 ± 14 µM in human embryonic kidney HEK-293 cells (10). Although Fernandes et al. (10) assigned their KmPi values in HEK-293 cells to PiT1, their cells most likely also expressed PiT2 mRNA, because another study (40) showed its presence in HEK-293 cells and kidney. These results are in agreement with the previous assignment of PiT1 as the major NaPi transporter in osteoblastic cells (20, 23) and type III transporters as the housekeeping NaPi transporters in human cells (16, 17, 40).
We found that human PiT1 and PiT2 sustained substantial Pi uptake in oocytes at pH values from 4.5 to 8.5 with a tendency to pH optima at 6.5 and 7.5 for both proteins. Human PiT1 NaPi uptake was previously investigated in oocytes at pH 7.5 and 8.5, and a higher reduction in uptake at pH 8.5 (55%) compared with pH 7.5 was observed (17). As found in the present study for human PiT2, mouse PiT2 was reported to sustain comparable levels of Pi transport in oocytes at pH 5.57.5. Moreover, mouse PiT2 also supported substantial levels of Pi uptake at pH 8.0 and 8.5, albeit significantly impaired compared with transport at pH 7.5 (1). The same tendency was observed for rat PiT2 at pH 7.5 and 8.5 (17); however, the Pi uptake levels in rat PiT2-expressing oocytes were in general surprisingly low (17) compared with those supported by human PiT2 (4, 5) (present work) and mouse PiT2 (1), hampering the full interpretation of these data. In mammalian cell lines originating from kidney, ovary, and connective tissue, the pH optima of the PiT proteins did not differ substantially from those found in oocytes; however, severely impaired uptake at pH 8.0 and 8.5 was observed (10, 22, 44). This underscores the difficulties in addressing general characteristics of proteins in mammalian cells, where a cell type-specific behavior might determine the outcome of the protein characterization.
Human PiT1 and PiT2 supported comparable levels of Pi uptake at Na+ concentrations varying from 0.5 to 100 mM when analyzed in oocytes. This Pi uptake was Na+ dose dependent and in agreement with results from similar studies of mouse PiT2 (1). Voltage-clamp studies of oocytes expressing rat PiT2 and human PiT1 proposed transport of 2 Na+:1 H2PO4 or 3 Na+:1HPO42 (16); our analyses of pH-dependent uptake indeed support the suggestion that both H2PO4 and HPO42 can be transported. Moreover, our 22Na+ uptake studies also are in agreement with uptake of a surplus Na+ to Pi. We also found that the PiT proteins are capable of sustaining striking levels of Pi uptake at low levels of Na+; however, in the human body, the physiological Na+ levels is in the range of 130145 mM, and thus it is unlikely that this ability is of physiological relevance.
The cotransport of Na+ and Pi by the PiT proteins are the two actions responsible for Pi import into cells. Human PiT2 residues D28, D506, E55, and E575 (4, 5) as well as S113 and S593 (31) were found to be critical for Pi transport function of PiT2 (4, 5, 31). The present study is the first to address the Na+ transport function of a PiT protein. We found that wild-type PiT2 was capable of transporting Na+ without the presence of Pi, emphasizing that Pi and Na+ transport occur as two distinct functions. However, a full understanding of the implication and relevance of this finding, i.e., whether PiT2 exhibits substrate-independent Na+ uptake, a phenomenon referred to as slippage, in its physiological environment in the mammalian cell, demands more investigations. Nevertheless, the analyses of a Pi transport knockout PiT2 mutant protein, PiT2 E55Q E91Q E575Q, did provide knowledge on the mechanism of the Na+ transport, showing that it can occur even though the Pi uptake function is abolished. The glutamates in human PiT2 positions 55, 91, and 575 are believed to locate to transmembrane domains (4, 9, 14, 32). A former study (5) revealed that E91 is dispensable, whereas E55 and E575 are critical for Pi transport of PiT2. The putative location of E55 and E575 make them unlikely to fulfill structural roles in the PiT proteins, and instead we have previously suggested that they were involved in function-dependent conformational changes or being parts of a ligand site for the coupling cation (5). However, the data presented in the present study clearly show that they are not participants in the Na+ translocation pathway. Rather, we suggest that E55 and E575 are involved in the coupling of Na+ transport to Pi uptake. Noticeably, the conserved nature of the glutamates in PiT2 positions 55 and 575 among members of the PiT family, including in those dependent on H+ for Pi uptake, suggest that the residues have similar roles in other PiT family members.
The modulation of PiT1- and PiT2-mediated Pi uptake by Ca2+ within 1 h of exposure is interesting. The Ca2+ concentration used in the present experiments is slightly lower than the free serum Ca2+ level (1.11.3 mM) in adult healthy individuals (26). We found an increase in Pi uptake by adding 1 mM Ca2+ to the uptake solution; however, it is tempting to speculate that Ca2+ plays a general regulating function in Pi uptake via PiT1 and PiT2, because serum Ca2+ levels are tightly controlled and serum Pi levels are not. Whether the effects of Ca2+ and Mg2+ occur directly on the PiT proteins is presently not known.
In summary, we have in the present study characterized human PiT1 and PiT2 transport functions at different levels. We have determined kinetic constants of both proteins for Pi and found that they correspond well to KmPi values determined for endogenously expressed human PiT proteins. We also have found that both proteins supported NaPi uptake at pH 4.58.5, but only PiT2 was capable of HPi uptake at acidic pH. Moreover, Ca2+ increased both PiT1- and PiT2-mediated Pi uptake in a manner suggesting a regulatory function of Ca2+. Dissection of the transport function of human PiT2 revealed glutamate residues critical for the coupling of Pi import to Na+ transport.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Beard SJ, Hashim R, Wu G, Binet MR, Hughes MN, and Poole RK. Evidence for the transport of zinc(II) ions via the pit inorganic phosphate transport system in Escherichia coli. FEMS Microbiol Lett 184: 231235, 2000.[CrossRef][Web of Science][Medline]
3. Beck GR Jr, Zerler B, and Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA 97: 83528357, 2000.
4. Bøttger P and Pedersen L. Evolutionary and experimental analyses of inorganic phosphate transporter PiT family reveals two related signature sequences harboring highly conserved aspartic acids critical for sodium-dependent phosphate transport function of human PiT2. FEBS J 272: 30603074, 2005.[CrossRef][Medline]
5. Bøttger P and Pedersen L. Two highly conserved glutamate residues critical for type III sodium-dependent phosphate transport revealed by uncoupling transport function from retroviral receptor function. J Biol Chem 277: 4274142747, 2002.
6. Chien ML, Foster JL, Douglas JL, and Garcia JV. The amphotropic murine leukemia virus receptor gene encodes a 71-kilodalton protein that is induced by phosphate depletion. J Virol 71: 45644570, 1997.[Abstract]
7. Chien ML, O'Neill E, and Garcia JV. Phosphate depletion enhances the stability of the amphotropic murine leukemia virus receptor mRNA. Virology 240: 109117, 1998.[CrossRef][Web of Science][Medline]
8. Daram P, Brunner S, Rausch C, Steiner C, Amrhein N, and Bucher M. Pht2, 1 encodes a low-affinity phosphate transporter from Arabidopsis. Plant Cell 11: 21532166, 1999.
9. Farrell KB, Russ JL, Murthy RK, and Eiden MV. Reassessing the role of region A in Pit1-mediated viral entry. J Virol 76: 76837693, 2002.
10. Fernandes I, Beliveau R, Friedlander G, and Silve C. NaPO4 cotransport type III (PiT1) expression in human embryonic kidney cells and regulation by PTH. Am J Physiol Renal Physiol 277: F543F551, 1999.
11. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 14: S300S304, 2003.
12. Good NE and Izawa S. Hydrogen ion buffers. Methods Enzymol 24: 5368, 1972.[Medline]
13. Harris RM, Webb DC, Howitt SM, and Cox GB. Characterization of PitA and PitB from Escherichia coli. J Bacteriol 183: 50085014, 2001.
14. Johann SV, Gibbons JJ, and O'Hara B. GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. J Virol 66: 16351640, 1992.
15. Johann SV, van Zeijl M, Cekleniak J, and O'Hara B. Definition of a domain of GLVR1 which is necessary for infection by gibbon ape leukemia virus and which is highly polymorphic between species. J Virol 67: 67336736, 1993.
16. Kavanaugh MP and Kabat D. Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int 49: 959963, 1996.[Web of Science][Medline]
17. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, and Miller AD. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 91: 70717075, 1994.
18. Miller DG and Miller AD. A family of retroviruses that utilize related phosphate transporters for cell entry. J Virol 68: 82708276, 1994.
19. Miller DG, Edwards RH, and Miller AD. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci USA 91: 7882, 1994.
20. Nielsen LB, Pedersen FS, and Pedersen L. Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone 28: 160166, 2001.[Medline]
21. O'Hara B, Johann SV, Klinger HP, Blair DG, Rubinson H, Dunn KJ, Sass P, Vitek SM, and Robins T. Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Differ 1: 119127, 1990.[Abstract]
22. Olah Z, Lehel C, Anderson WB, Eiden MV, and Wilson CA. The cellular receptor for gibbon ape leukemia virus is a novel high affinity sodium-dependent phosphate transporter. J Biol Chem 269: 2542625431, 1994.
23. Palmer G, Bonjour JP, and Caverzasio J. Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology 138: 52025209, 1997.
24. Palmer G, Zhao J, Bonjour J, Hofstetter W, and Caverzasio J. In vivo expression of transcripts encoding the Glvr-1 phosphate transporter/retrovirus receptor during bone development. Bone 24: 17., 1999.[Medline]
25. Pedersen L, Johann SV, van Zeijl M, Pedersen FS, and O'Hara B. Chimeras of receptors for gibbon ape leukemia virus/feline leukemia virus B and amphotropic murine leukemia virus reveal different modes of receptor recognition by retrovirus. J Virol 69: 24012405, 1995.[Abstract]
26. Portale AA. Blood calcium, phosphorus, and magnesium. In: Primers on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, edited by Favus MJ. New York: Lippincott Williams and Wilkins, 2005.
27. Raymond JR, Fargin A, Middleton JP, Graff JM, McNeill Haupt D, Caron MG, Lefkowitz RJ, and Dennis VW. The human 5-HT1A receptor expressed in HeLa cells stimulates sodium-dependent phosphate uptake via protein kinase C. J Biol Chem 264: 2194321950, 1989.
28. Sabatino DE, Do BQ, Pyle LC, Seidel NE, Girard LJ, Spratt SK, Orlic D, and Bodine DM. Amphotropic or gibbon ape leukemia virus retrovirus binding and transduction correlates with the level of receptor mRNA in human hematopoietic cell lines. Blood Cells Mol Dis 23: 422433, 1997.[CrossRef][Web of Science][Medline]
29. Saier MH Jr. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol Mol Biol Rev 64: 354411, 2000.
30. Salaün C, Gyan E, Rodrigues P, and Heard JM. Pit2 assemblies at the cell surface are modulated by extracellular inorganic phosphate concentration. J Virol 76: 43044311, 2002.
31. Salaün C, Marechal V, and Heard JM. Transport-deficient Pit2 phosphate transporters still modify cell surface oligomers structure in response to inorganic phosphate. J Mol Biol 340: 3947, 2004.[CrossRef][Web of Science][Medline]
32. Salaün C, Rodrigues P, and Heard JM. Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor. J Virol 75: 55845592, 2001.
33. Schecher WD and McAvoy DC. MINEQL+: a software environment for chemical equilibrium modeling. Comput Environ Urban Syst 16: 6576, 1992.
34. Schecher WD and McAvoy DC. MINEQL+ User's Manual. Hollowell, ME: Environmental Research Software, 1994.
35. Shoemarker DG, Bender CA, and Gunn RB. Sodium-phosphate cotransport in human red blood cells. Kinetics and role in membrane metabolism. J Gen Physiol 92: 449474, 1988.
36. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNB, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy, 1997, p. 146189.
37. Takeuchi Y, Vile RG, Simpson G, O'Hara B, Collins MK, and Weiss RA. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J Virol 66: 12191222, 1992.
38. Tatsumi S, Segawa H, Morita K, Haga H, Kouda T, Yamamoto H, Inoue Y, Nii T, Katai K, Taketani Y, Miyamoto KI, and Takeda E. Molecular cloning and hormonal regulation of PiT-1, a sodium-dependent phosphate cotransporter from rat parathyroid glands. Endocrinology 139: 16921699, 1998.
39. Timmer RT and Gunn RB. The molecular basis for Na-dependent phosphate transport in human erythrocytes and K562 cells. J Gen Physiol 116: 363378, 2000.
40. Uckert W, Willimsky G, Pedersen FS, Blankenstein T, and Pedersen L. RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum Gene Ther 9: 26192627, 1998.[CrossRef][Web of Science][Medline]
41. Van Veen HW, Abee T, Kortstee GJ, Konings WN, and Zehnder AJ. Translocation of metal phosphate via the phosphate inorganic transport system of Escherichia coli. Biochemistry 33: 17661770, 1994.[CrossRef][Medline]
42. Van Zeijl M, Johann SV, Closs E, Cunningham J, Eddy R, Shows TB, and O'Hara B. A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci USA 91: 11681172, 1994.
43. Wain HM, Bruford EA, Lovering RC, Lush MJ, Wright MW, and Povey S. Guidelines for human gene nomenclature. Genomics 79: 464470, 2002.[CrossRef][Web of Science][Medline]
44. Wilson CA, Eiden MV, Anderson WB, Lehel C, and Olah Z. The dual-function hamster receptor for amphotropic murine leukemia virus (MuLV), 10A1 MuLV, and gibbon ape leukemia virus is a phosphate symporter. J Virol 69: 534537, 1995.[Abstract]
45. Wilson CA, Farrell KB, and Eiden MV. Properties of a unique form of the murine amphotropic leukemia virus receptor expressed on hamster cells. J Virol 68: 76977703, 1994.
This article has been cited by other articles:
![]() |
L. Beck, C. Leroy, C. Salaun, G. Margall-Ducos, C. Desdouets, and G. Friedlander Identification of a Novel Function of PiT1 Critical for Cell Proliferation and Independent of Its Phosphate Transport Activity J. Biol. Chem., November 6, 2009; 284(45): 31363 - 31374. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Virkki, J. Biber, H. Murer, and I. C. Forster Phosphate transporters: a tale of two solute carrier families Am J Physiol Renal Physiol, September 1, 2007; 293(3): F643 - F654. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ravera, L. V. Virkki, H. Murer, and I. C. Forster Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements Am J Physiol Cell Physiol, August 1, 2007; 293(2): C606 - C620. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |